Related Experiment Video
Updated: Jan 29, 2026

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1
Zhiyong Sheng1, Yun Xu2, Fuxin Li1
1Intensive Care Unit, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China.
Abstract:
CSN5 is a critical subunit of the COP9 signalosome (CSN) and has been involved in various cellular processes, but little is known about the role of CSN5 in cardiac disease. In the present study, we found that the expression of CSN5 was increased in Angiotensin II (Ang II)-induced cardiac hypertrophic mice hearts and Ang II-treated cardiomyocytes. We also observed that overexpression of CSN5 significantly inhibited Ang II-induced cardiac hypertrophy, whereas CSN5 silence exhibited the opposite phenotypes. Further investigation demonstrated that CSN5 maintained the activity of AMP-activated protein kinase (AMPK) in cardiomyocyte by enhancement of LKB1. Mechanistically, we found that CSN5 directly interacted and deubiquitinated LKB1 for its stabilization in cardiomyocytes. Finally, our results demonstrated that the anti-hypertrophic effect of CSN5 was partially dependent on stabilization of LKB1. Collectively, these findings suggested that strategies based on activation of CSN5/LKB1 axis might be promising in the treatment of hypertrophic cardiomyopathy.
Insights
The COP9 signalosome subunit CSN5 protects against cardiac hypertrophy by stabilizing LKB1, a key regulator of AMP-activated protein kinase (AMPK). Activating the CSN5/LKB1 pathway may offer a novel treatment for hypertrophic cardiomyopathy.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Biology
Background:
- The COP9 signalosome (CSN) subunit CSN5 plays roles in cellular processes, but its function in cardiac disease remains unclear.
- Cardiac hypertrophy is a significant risk factor for heart failure.
Purpose of the Study:
- To investigate the role of CSN5 in Angiotensin II (Ang II)-induced cardiac hypertrophy.
- To elucidate the molecular mechanism by which CSN5 affects cardiac hypertrophy.
Main Methods:
- Utilized Angiotensin II (Ang II) to induce cardiac hypertrophy in mouse models and cultured cardiomyocytes.
- Examined CSN5 expression levels and its effects on cardiac hypertrophy through overexpression and silencing.
- Investigated the interaction between CSN5 and LKB1, and its impact on AMP-activated protein kinase (AMPK) activity.
Main Results:
- CSN5 expression was upregulated in Ang II-induced cardiac hypertrophy.
- Overexpression of CSN5 inhibited Ang II-induced cardiac hypertrophy, while CSN5 silencing exacerbated it.
- CSN5 directly interacted with and deubiquitinated LKB1, enhancing its stability and maintaining AMPK activity.
Conclusions:
- CSN5 plays a protective role against cardiac hypertrophy by stabilizing LKB1 and activating the AMPK pathway.
- The CSN5/LKB1 axis represents a potential therapeutic target for hypertrophic cardiomyopathy.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Nuclear Stability
To hold positively charged protons together...
RNA Stability
Stability
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...
Stability of structures
Pole and System Stability
Simple poles are unique roots of the denominator polynomial. Each simple pole corresponds to a distinct solution to the system's characteristic equation, typically resulting in exponential decay terms in the system's...

